July 26, 2018 / 5:11 AM / 5 months ago

BRIEF-Cosmo Pharmaceuticals H1 Revenue Up 15.2 Pct To EUR 36.7 Million

July 26 (Reuters) - Cosmo Pharmaceuticals NV:

* H1 REVENUE UP 15.2% TO EUR36.7M DRIVEN BY UP-FRONT LICENSE FEESÂ

* H1 LOSS FOR PERIOD EUR7.8M INCLUDING SHARE OF CASSIOPEA LOSS EUR2.9M

* CASH AND INVESTMENTS IN FUNDS AND DEBT SECURITIES EUR230.2M VERSUS EUR247.1M AT FY17 YE

* H1 OPERATING LOSS EUR7.2M VERSUS EUR4.3M LAST YEAR Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below